Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 29,814 | $4.173 | $124,414 | 381,009 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 180,677 | $4.173 | $753,965 | 1,527,753 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 40,102 | $4.173 | $167,346 | 492,879 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:52 pm | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 25,311 | $4.173 | $105,623 | 349,867 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:51 pm | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 58,254 | $4.173 | $243,094 | 446,112 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:51 pm | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 15,741 | $4.173 | $65,687 | 283,617 (Direct) | View |
| 2026-03-10 Sale | 2026-03-11 12:50 pm | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 45,791 | $4.173 | $191,086 | 319,480 (Indirect Direct) | View |
| 2025-10-15 Sale | 2025-10-17 2:01 pm | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 67,575 | $7.01 | $473,701 | 242,771 (Indirect Direct) | View |
| 2025-10-15 Sale | 2025-10-17 2:01 pm | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 20,272 | $7 | $141,904 | 282,475 (Direct) | View |
| 2025-10-15 Sale | 2025-10-17 2:00 pm | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remarks | 10,000 | $7 | $70,000 | 268,323 (Direct) | View |
| 2025-09-26 Sale | 2025-09-29 4:26 pm | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 91,343 | $6.0343 | $551,191 | 923,430 (Direct) | View |
| 2025-09-26 Sale | 2025-09-29 4:26 pm | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remarks | 10,000 | $6.3 | $63,000 | 278,323 (Direct) | View |
| 2025-09-19 Sale | 2025-09-22 5:25 pm | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 400 | $6 | $2,400 | 1,014,773 (Direct) | View |
| 2025-09-04 Sale | 2025-09-08 7:06 pm | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 62,180 | $5 | $310,900 | 285,346 (Indirect Direct) | View |
| 2025-09-05 Sale | 2025-09-08 5:13 pm | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remarks | 15,000 | $5.3 | $79,500 | 288,323 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 80,000 | $0 | 381,009 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 42,500 | $4.29 | 381,009 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 262,000 | $0 | 1,527,753 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Barber Daniel President and CEO | 523,000 | $4.29 | 1,527,753 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 80,000 | $0 | 492,879 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 50,000 | $4.29 | 492,879 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 100,000 | $0 | 349,867 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:52 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 75,000 | $4.29 | 349,867 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:51 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 165,000 | $0 | 446,112 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:51 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 75,000 | $0 | 283,617 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:51 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 42,500 | $4.29 | 283,617 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:50 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 122,500 | $0 | 319,480 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 12:49 pm | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Davis Matthew W. Chief Development Officer | 50,000 | $0 | 150,000 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 09:25 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Greenhawt Matthew J. Chief Medical Officer | 75,000 | $0 | 127,000 (Direct) | View |
| 2026-03-09 Option Award | 2026-03-11 09:25 am | N/A 2036-03-09 | Aquestive Therapeutics Inc. | AQST | Greenhawt Matthew J. Chief Medical Officer | 50,000 | $4.29 | 127,000 (Direct) | View |
Ownership | 2026-03-11 09:19 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Greenhawt Matthew J. Chief Medical Officer | 0 | $0 | 2,000 (Indirect) | View |
| 2025-12-04 Option Award | 2025-12-05 1:06 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. Chief People Officer | 20,000 | $0 | 288,323 (Direct) | View |
| 2025-12-02 Tax Withholding | 2025-12-04 10:39 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 2,083 | $5.93 | 200,178 (Direct) | View |
| 2025-11-10 Option Award | 2025-11-12 09:35 am | N/A 2035-11-10 | Aquestive Therapeutics Inc. | AQST | Davis Matthew W. Chief Development Officer | 50,000 | $0 | 100,000 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 2:01 pm | N/A 2031-06-10 | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 25,000 | $0 | 242,771 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-17 2:01 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 25,000 | $3.1027 | 242,771 (Direct) | View |
| 2025-09-04 Exercise | 2025-09-08 7:06 pm | N/A 2029-08-09 | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 50,000 | $0 | 285,346 (Direct) | View |
| 2025-09-04 Exercise | 2025-09-08 7:06 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 25,000 | $3.15 | 285,346 (Direct) | View |
| 2025-09-04 Exercise | 2025-09-08 7:06 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 25,000 | $0.7063 | 285,346 (Direct) | View |
| 2025-08-14 Option Award | 2025-08-15 08:41 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry Chief Commercial Officer | 25,000 | $0 | 181,858 (Direct) | View |
| 2025-08-09 Tax Withholding | 2025-08-12 10:11 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 10,819 | $3.9 | 302,747 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 2:13 pm | 2026-06-11 2035-06-11 | Aquestive Therapeutics Inc. | AQST | BROWN GREGORY B Director | 42,000 | $3.41 | 117,085 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 1:59 pm | 2026-06-11 2035-06-11 | Aquestive Therapeutics Inc. | AQST | Krop Julie Director | 42,000 | $3.41 | 42,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 1:59 pm | 2026-06-11 2035-06-11 | Aquestive Therapeutics Inc. | AQST | MORRIS TIMOTHY E Director | 42,000 | $3.41 | 42,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 1:59 pm | 2026-06-11 2035-06-11 | Aquestive Therapeutics Inc. | AQST | Jenkins Abigail L. Director | 42,000 | $3.41 | 42,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 1:58 pm | 2026-06-11 2035-06-11 | Aquestive Therapeutics Inc. | AQST | Cochran John Director | 42,000 | $3.41 | 141,486 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 1:57 pm | 2026-06-11 2035-06-11 | Aquestive Therapeutics Inc. | AQST | Taglietti Marco Director | 42,000 | $3.41 | 42,000 (Direct) | View |
| 2025-06-09 Tax Withholding | 2025-06-10 2:12 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 2,714 | $3.54 | 156,858 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-15 12:59 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP, Regulatory Affairs | 20,000 | $0 | 202,261 (Direct) | View |
Ownership | 2025-05-07 09:10 am | N/A N/A | Aquestive Therapeutics Inc. | AQST | Cioffi Melina SVP Regulatory Affairs | 0 | $0 | 259,761 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:49 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 180,000 | $0 | 408,552 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 5:49 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 4,572 | $2.54 | 408,552 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:49 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Wargacki Stephen Chief Science Officer | 28,290 | $2.65 | 408,552 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 120,000 | $0 | 337,526 (Direct) | View |
| 2025-03-10 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 2,182 | $2.54 | 337,526 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Jung Cassie Chief Operating Officer | 15,358 | $2.65 | 337,526 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 170,000 | $0 | 399,366 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | TOTH A ERNEST JR Chief Financial Officer | 18,929 | $2.65 | 399,366 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 100,000 | $0 | 343,566 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Kraus Carl N Chief Medical Officer | 8,115 | $2.65 | 343,566 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:48 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 125,000 | $0 | 194,572 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:48 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Korczynski Sherry SVP Sales and Marketing | 5,428 | $2.65 | 194,572 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:47 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 170,000 | $0 | 462,981 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | BRAENDER LORI J Chief Legal Officer | 20,250 | $2.65 | 462,981 (Direct) | View |
| 2025-03-07 Option Award | 2025-03-11 5:47 pm | N/A 2035-03-07 | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark | 120,000 | $0 | 343,323 (Direct) | View |
| 2025-03-07 Tax Withholding | 2025-03-11 5:47 pm | N/A N/A | Aquestive Therapeutics Inc. | AQST | Boyd Peter E. See Remark | 14,305 | $2.65 | 343,323 (Direct) | View |